NCT05429190 Validation of SMS Protocol for HCC Screening in High-risk Patients Status ENROLLING_BY_INVITATION Phase N/A
NCT05420922 Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC Status UNKNOWN Phase N/A
NCT05418387 A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona Status WITHDRAWN Phase NA
NCT05416073 Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma Status UNKNOWN Phase PHASE4
NCT05411926 Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular Carcinoma Status UNKNOWN Phase N/A
NCT05409482 A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma Status RECRUITING Phase N/A
NCT05408221 the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma Status RECRUITING Phase PHASE2/PHASE3
NCT05407519 A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection Status RECRUITING Phase PHASE2
NCT05397860 Radiofrequency Ablation With Gradual Radiofrequency Energy Increment for Hepatocellular Carcinoma Treatment Status UNKNOWN Phase NA
NCT05394259 A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05391867 Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT05375370 Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA Status RECRUITING Phase NA
NCT05371873 A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer Status UNKNOWN Phase N/A
NCT05363722 A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1
NCT05359939 A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT05359861 Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT05355662 Prognosis Analysis of Elderly Donor Liver in Liver Transplantation Status COMPLETED Phase N/A
NCT05352646 NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection Status UNKNOWN Phase PHASE1